Spots Global Cancer Trial Database for Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion

Official Title: Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion

Study ID: NCT06315595

Conditions

Prostate Neoplasm

Interventions

Non-Interventional Study

Study Description

Brief Summary: This study evaluates contrast-enhanced MR angiography and contrast-enhanced MR perfusion imaging for the visualization of blood vessels and enhancing tissues with better spatial detail and improved temporal fidelity compared to current methods.

Detailed Description: PRIMARY OBJECTIVE: I. To study how a variety of technological approaches in MRI can be used to provide improved performance contrast-enhanced MR imaging as used for angiography and perfusion. OUTLINE: This is an observational study. Participants are assigned to 1 of 3 groups. GROUP 1: Participants undergo magnetic resonance imaging (MRI) on study. Participants may also undergo blood sample collection on study. GROUP 2: Participants receive gadolinium based MR contrast agent intravenously (IV) and undergo MRI on study. Participants may also undergo blood sample collection on study. GROUP 3: Participants receive gadolinium based MR contrast agent IV and undergo up to two MRIs on study. Participants may also undergo blood sample collection on study.